RESEARCH PEPTIDE FUNDAMENTALS / COLOPHON
Contact the Editorial Desk
Correspondence on citations, corrections, and research updates — exactly what a guide like this is most useful to hear about.
Editorial correspondence
The primer is glad to hear about the research record itself: a citation that reads wrong, a newly published trial, a changed regulatory status, or a peer-reviewed study on Ipamorelin, NAD+, Semaglutide, or Tesamorelin that ought to sit on the references page. Corrections like these get read closely, because accurate citations are the entire point.
The handiest messages name the specific page, quote the exact passage, and attach a supporting source — a DOI or PubMed link where possible — so an edit can be checked before it goes in.
Editorial mailbox: editors@purecorepeptides.com
Where the primer stops
So no note goes unanswered for the wrong reason, here is what a primer can't do. It won't recommend or comment on anyone's personal use of these compounds; won't suggest a dose, schedule, or route for an individual; won't judge whether a cited trial applies to a particular person; and won't help find, source, or vet a supplier. Semaglutide and Tesamorelin are prescription medicines available only through a licensed provider, so a medical question belongs with a licensed clinician, not this mailbox. Replies aren't guaranteed and can take a while — the inbox is checked now and then, not around the clock.